Skip to content
Screener

Danaher DHR Nonrecurring revenue — Sales

Other product segments

Recurring revenue
$5.2B+4.6%

Similar metrics at other companies

Veralto logo
VLTONonrecurring — Sales
$559M+5.5%
Ralliant Corp logo
RALTest and Measurement — Sales
$210.2M+11.5%
DXP Enterprises logo
DXPEOrganic Sales — Sales
$526.61M+11.1%
DXP Enterprises logo
DXPEAcquisition Sales — Sales
$49.85M+103%
Aebi Schmidt Holding AG logo
AEBIAfter Sales — Sales
$73.88M+59.6%
Vontier logo
VNTSales of products — Sales
$691.9M+0.9%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$136.93B+0.4%
Enterprise value$160.44B+5.5%
P/E34.2×-5.7×
P/S5.5×-0.2×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Danaher’s 10-Q, filed July 21, 2026.

Filed
Jul 20, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000313616-26-000161
For the Three-Month Period Ended June 26, 2026:Biotechnology / For the Three-Month Period Ended June 26, 2026:Life SciencesDiagnosticsTotal
Total$1,920$1,879$2,466$6,265
Revenue type:
Recurring$1,722$1,268$2,210$5,200
Nonrecurring1986112561,065
Total$1,920$1,879$2,466$6,265
For the Three-Month Period Ended June 27, 2025:
Geographical region:
North America(a)$612$762$1,064$2,438

Item 1. Financial Statements

FAQ

What is Danaher's nonrecurring revenue — sales?
Danaher (DHR) reported nonrecurring revenue — sales of $1.07B in Q2 2026.
How has Danaher's nonrecurring revenue — sales changed year-over-year?
Danaher's nonrecurring revenue — sales increased by 10.2% year-over-year, from $966M to $1.07B.
What is the long-term trend for Danaher's nonrecurring revenue — sales?
Over 4 years (2021 to 2025), Danaher's nonrecurring revenue — sales has grown at a -5.9% compound annual growth rate (CAGR), from $5.67B to $4.44B.
What does nonrecurring revenue — sales mean?
This metric represents revenue generated from one-time sales transactions, such as capital equipment purchases or non-contractual service engagements, within a specific business segment. It excludes recurring revenue streams like long-term service contracts, subscriptions, or consumable replenishment cycles. Tracking this helps investors distinguish between volatile, project-based income and the stable, predictable revenue base of the company.

Ask your AI about Danaher's nonrecurring revenue — sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude